These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37241152)

  • 41. Best-corrected visual acuity and retinal thickness are associated with improved cortical visual processing in treated wet AMD patients.
    Vottonen P; Pääkkönen A; Tarkka IM; Kaarniranta K
    Acta Ophthalmol; 2015 Nov; 93(7):621-5. PubMed ID: 26031317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Objective visual assessment of antiangiogenic treatment for wet age-related macular degeneration.
    Baseler HA; Gouws A; Crossland MD; Leung C; Tufail A; Rubin GS; Morland AB
    Optom Vis Sci; 2011 Oct; 88(10):1255-61. PubMed ID: 21705938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased electroretinogram a-wave amplitude after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Skaat A; Solomon A; Moroz I; Hai OV; Rechtman E; Vishnevskia Dai V; Rotenstreich Y
    Acta Ophthalmol; 2011 May; 89(3):e269-73. PubMed ID: 20946333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rescue of retinal function by macular translocation surgery in age-related macular degeneration and other diseases with subfoveal choroidal neovascularization.
    Terasaki H
    Nagoya J Med Sci; 2001 May; 64(1-2):1-9. PubMed ID: 11486596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-related macular degeneration: using morphological predictors to modify current treatment protocols.
    Ashraf M; Souka A; Adelman RA
    Acta Ophthalmol; 2018 Mar; 96(2):120-133. PubMed ID: 29130626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study.
    Koizumi H; Yamamoto A; Ogasawara M; Maruko I; Hasegawa T; Itagaki K; Sekiryu T; Okada AA; Iida T
    Jpn J Ophthalmol; 2020 Jul; 64(4):338-345. PubMed ID: 32447586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
    Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
    Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between structural and functional treatment outcomes in neovascular age-related macular degeneration.
    Haji H; Gianniou C; Brynskov T; Sørensen TL; Olsen R; Krogh Nielsen M
    Acta Ophthalmol; 2023 Mar; 101(2):177-184. PubMed ID: 36036674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extramacular Drusen and Progression of Age-Related Macular Degeneration: Age Related Eye Disease Study 2 Report 30.
    Domalpally A; Xing B; Pak JW; Agrón E; Ferris FL; Clemons TE; Chew EY
    Ophthalmol Retina; 2023 Feb; 7(2):111-117. PubMed ID: 35940477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
    Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
    Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
    Bhisitkul RB; Desai SJ; Boyer DS; Sadda SR; Zhang K
    Ophthalmology; 2016 Jun; 123(6):1269-77. PubMed ID: 26996339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss.
    Borrelli E; Barresi C; Lari G; Berni A; Battista M; Reibaldi M; Cascavilla ML; Bandello F
    Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):21. PubMed ID: 37074695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration.
    Kambhampati SP; Bhutto IA; Wu T; Ho K; McLeod DS; Lutty GA; Kannan RM
    J Control Release; 2021 Jul; 335():527-540. PubMed ID: 34058271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
    Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J
    Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration.
    Daftarian N; Zandi S; Piryaie G; Nikougoftar Zarif M; Ranaei Pirmardan E; Yamaguchi M; Behzadian Nejad Q; Hasanpour H; Samiei S; Pfister IB; Soheili ZS; Nakao S; Barakat A; Garweg JG; Ahmadieh H; Hafezi-Moghadam A
    FASEB J; 2020 Jun; 34(6):8001-8011. PubMed ID: 32333612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
    ; Maguire MG; Martin DF; Ying GS; Jaffe GJ; Daniel E; Grunwald JE; Toth CA; Ferris FL; Fine SL
    Ophthalmology; 2016 Aug; 123(8):1751-1761. PubMed ID: 27156698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment.
    Munk MR; Kiss C; Huf W; Sulzbacher F; Roberts P; Mittermüller TJ; Sacu S; Simader C; Schmidt-Erfurth U
    Am J Ophthalmol; 2013 Oct; 156(4):633-43. PubMed ID: 23891335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.